Literature DB >> 19372249

T-cell activation under hypoxic conditions enhances IFN-gamma secretion.

Jessica Roman1, Tirumalai Rangasamy, Jia Guo, Siva Sugunan, Nida Meednu, Gopinath Packirisamy, Larissa A Shimoda, Amit Golding, Gregg Semenza, Steve N Georas.   

Abstract

Secondary lymphoid organs and peripheral tissues are characterized by hypoxic microenvironments, both in the steady state and during inflammation. Although hypoxia regulates T-cell metabolism and survival, very little is known about whether or how hypoxia influences T-cell activation. We stimulated mouse CD4(+) T cells in vitro with antibodies directed against the T-cell receptor (CD3) and CD28 under normoxic (20% O(2)) and hypoxic (1% O(2)) conditions. Here we report that stimulation under hypoxic conditions augments the secretion of effector CD4(+) T-cell cytokines, especially IFN-gamma. The enhancing effects of hypoxia on IFN-gamma secretion were independent of mouse strain, and were also unaffected using CD4(+) T cells from mice lacking one copy of the gene encoding hypoxia-inducible factor-1alpha. Using T cells from IFN-gamma receptor-deficient mice and promoter reporter studies in transiently transfected Jurkat T cells, we found that the enhancing effects of hypoxia on IFN-gamma expression were not due to effects on IFN-gamma consumption or proximal promoter activity. In contrast, deletion of the transcription factor, nuclear erythroid 2 p45-related factor 2 attenuated the enhancing effect of hypoxia on IFN-gamma secretion and other cytokines. We conclude that hypoxia is a previously underappreciated modulator of effector cytokine secretion in CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19372249      PMCID: PMC2809218          DOI: 10.1165/rcmb.2008-0139OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  37 in total

1.  Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions.

Authors:  C C Caldwell; H Kojima; D Lukashev; J Armstrong; M Farber; S G Apasov; M V Sitkovsky
Journal:  J Immunol       Date:  2001-12-01       Impact factor: 5.422

2.  Cobalt induces heme oxygenase-1 expression by a hypoxia-inducible factor-independent mechanism in Chinese hamster ovary cells: regulation by Nrf2 and MafG transcription factors.

Authors:  P Gong; B Hu; D Stewart; M Ellerbe; Y G Figueroa; V Blank; B S Beckman; J Alam
Journal:  J Biol Chem       Date:  2001-05-16       Impact factor: 5.157

3.  Nonhypoxic pathway mediates the induction of hypoxia-inducible factor 1alpha in vascular smooth muscle cells.

Authors:  D E Richard; E Berra; J Pouyssegur
Journal:  J Biol Chem       Date:  2000-09-01       Impact factor: 5.157

4.  Requirements for T lymphocyte migration in explanted lymph nodes.

Authors:  Julie H Huang; L Isabel Cárdenas-Navia; Charles C Caldwell; Troy J Plumb; Caius G Radu; Paulo N Rocha; Tuere Wilder; Jonathan S Bromberg; Bruce N Cronstein; Michail Sitkovsky; Mark W Dewhirst; Michael L Dustin
Journal:  J Immunol       Date:  2007-06-15       Impact factor: 5.422

Review 5.  Regulation of immunological homeostasis in the respiratory tract.

Authors:  Patrick G Holt; Deborah H Strickland; Matthew E Wikström; Frode L Jahnsen
Journal:  Nat Rev Immunol       Date:  2008-02       Impact factor: 53.106

6.  Partial HIF-1alpha deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia.

Authors:  L A Shimoda; D J Manalo; J S Sham; G L Semenza; J T Sylvester
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-07       Impact factor: 5.464

7.  Survival from hypoxia in C. elegans by inactivation of aminoacyl-tRNA synthetases.

Authors:  Lori L Anderson; Xianrong Mao; Barbara A Scott; C Michael Crowder
Journal:  Science       Date:  2009-01-30       Impact factor: 47.728

8.  HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha.

Authors:  Zoltan Arany; Shi-Yin Foo; Yanhong Ma; Jorge L Ruas; Archana Bommi-Reddy; Geoffrey Girnun; Marcus Cooper; Dina Laznik; Jessica Chinsomboon; Shamina M Rangwala; Kwan Hyuck Baek; Anthony Rosenzweig; Bruce M Spiegelman
Journal:  Nature       Date:  2008-02-21       Impact factor: 49.962

9.  Enhanced interferon-gamma gene expression in T Cells and reduced ovalbumin-dependent lung eosinophilia in hypoxia-inducible factor-1-alpha-deficient mice.

Authors:  Jia Guo; Wenju Lu; Larissa A Shimoda; Gregg L Semenza; Steve N Georas
Journal:  Int Arch Allergy Immunol       Date:  2009-01-06       Impact factor: 2.749

10.  HIF-1 induction attenuates Nrf2-dependent IL-8 expression in human endothelial cells.

Authors:  Agnieszka Loboda; Anna Stachurska; Urszula Florczyk; Dominika Rudnicka; Agnieszka Jazwa; Joanna Wegrzyn; Magdalena Kozakowska; Krystyna Stalinska; Lorenz Poellinger; Anna-Liisa Levonen; Seppo Yla-Herttuala; Alicja Jozkowicz; Jozef Dulak
Journal:  Antioxid Redox Signal       Date:  2009-07       Impact factor: 8.401

View more
  28 in total

1.  Glut1-mediated glucose transport regulates HIV infection.

Authors:  Séverine Loisel-Meyer; Louise Swainson; Marco Craveiro; Leal Oburoglu; Cédric Mongellaz; Caroline Costa; Marion Martinez; François-Loic Cosset; Jean-Luc Battini; Leonard A Herzenberg; Leonore A Herzenberg; Kondala R Atkuri; Marc Sitbon; Sandrina Kinet; Els Verhoeyen; Naomi Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  Quercetin and hyperthermia modulate cisplatin-induced DNA damage in tumor and normal tissues in vivo.

Authors:  Nada Oršolić; Nikola Car
Journal:  Tumour Biol       Date:  2014-03-29

3.  Interferon-α signaling promotes embryonic HSC maturation.

Authors:  Peter Geon Kim; Matthew C Canver; Catherine Rhee; Samantha J Ross; June V Harriss; Ho-Chou Tu; Stuart H Orkin; Haley O Tucker; George Q Daley
Journal:  Blood       Date:  2016-04-19       Impact factor: 22.113

4.  Germinal Center Hypoxia Potentiates Immunoglobulin Class Switch Recombination.

Authors:  Robert K Abbott; Molly Thayer; Jasmine Labuda; Murillo Silva; Phaethon Philbrook; Derek W Cain; Hidefumi Kojima; Stephen Hatfield; Shalini Sethumadhavan; Akio Ohta; Ellis L Reinherz; Garnett Kelsoe; Michail Sitkovsky
Journal:  J Immunol       Date:  2016-10-19       Impact factor: 5.422

Review 5.  Hypoxia in the glioblastoma microenvironment: shaping the phenotype of cancer stem-like cells.

Authors:  Nicole Colwell; Mioara Larion; Amber J Giles; Ashlee N Seldomridge; Saman Sizdahkhani; Mark R Gilbert; Deric M Park
Journal:  Neuro Oncol       Date:  2017-07-01       Impact factor: 12.300

6.  Hypoxia-induced and A2A adenosine receptor-independent T-cell suppression is short lived and easily reversible.

Authors:  Akio Ohta; Manasa Madasu; Meenakshi Subramanian; Radhika Kini; Graham Jones; Alexander Choukèr; Akiko Ohta; Michail Sitkovsky
Journal:  Int Immunol       Date:  2013-10-22       Impact factor: 4.823

7.  Post-traumatic hypoxia is associated with prolonged cerebral cytokine production, higher serum biomarker levels, and poor outcome in patients with severe traumatic brain injury.

Authors:  Edwin B Yan; Laveniya Satgunaseelan; Eldho Paul; Nicole Bye; Phuong Nguyen; Doreen Agyapomaa; Thomas Kossmann; Jeffrey V Rosenfeld; Maria Cristina Morganti-Kossmann
Journal:  J Neurotrauma       Date:  2014-01-09       Impact factor: 5.269

Review 8.  The Redox-Metabolic Couple of T Lymphocytes: Potential Consequences for Hypertension.

Authors:  Cassandra M Moshfegh; Adam J Case
Journal:  Antioxid Redox Signal       Date:  2020-04-30       Impact factor: 8.401

Review 9.  Targeting Glioblastoma Stem Cells: A Review on Biomarkers, Signal Pathways and Targeted Therapy.

Authors:  Xuejia Tang; Chenghai Zuo; Pengchao Fang; Guojing Liu; Yongyi Qiu; Yi Huang; Rongrui Tang
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

10.  In vivo T cell activation in lymphoid tissues is inhibited in the oxygen-poor microenvironment.

Authors:  Akio Ohta; Rohan Diwanji; Radhika Kini; Meenakshi Subramanian; Akiko Ohta; Michail Sitkovsky
Journal:  Front Immunol       Date:  2011-07-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.